U.K. Geneticists Concerned Patent Ruling On Breast Cancer Gene Test Could Stifle Innovation
A recent ruling by the European Patent Office could make it more difficult and costly for health care providers in the United Kingdom to test for the BRCA1 genetic mutation, which can increase a woman’s risk for breast cancer, London’s
More: continued here
Filed under: Breast Cancer on December 11th, 2008